William Blair Comments on agilon health, inc.’s Q3 2023 Earnings (NYSE:AGL)

agilon health, inc. (NYSE:AGL – Get Rating) – Research analysts at William Blair issued their Q3 2023 earnings per share estimates for shares of agilon health in a research note issued on Wednesday, March 1st. William Blair analyst R. Daniels forecasts that the company will post earnings of ($0.05) per share for the quarter. The consensus estimate for agilon health’s current full-year earnings is ($0.04) per share. William Blair also issued estimates for agilon health’s Q4 2023 earnings at ($0.13) EPS, FY2023 earnings at ($0.15) EPS and FY2024 earnings at $0.11 EPS.

A number of other equities analysts have also issued reports on the company. The Goldman Sachs Group cut their target price on agilon health from $38.00 to $34.00 and set a “buy” rating on the stock in a research report on Tuesday, November 15th. Wells Fargo & Company cut their target price on agilon health from $28.00 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 15th. Deutsche Bank Aktiengesellschaft boosted their price target on agilon health from $26.00 to $28.00 in a report on Friday. Finally, Stifel Nicolaus assumed coverage on agilon health in a report on Thursday, December 8th. They issued a “buy” rating and a $23.00 price target for the company. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $28.63.

agilon health Stock Performance

agilon health stock opened at $25.22 on Monday. The stock’s 50 day moving average price is $20.31 and its 200 day moving average price is $20.19. The firm has a market capitalization of $10.42 billion, a PE ratio of -97.00 and a beta of 1.09. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.48 and a current ratio of 2.71. agilon health has a one year low of $14.82 and a one year high of $28.36.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently modified their holdings of AGL. IFP Advisors Inc raised its position in agilon health by 236.3% during the third quarter. IFP Advisors Inc now owns 1,231 shares of the company’s stock valued at $38,000 after buying an additional 865 shares during the period. Van ECK Associates Corp acquired a new position in agilon health during the third quarter valued at $45,000. Lazard Asset Management LLC acquired a new position in agilon health in the 1st quarter worth about $69,000. Vigilant Capital Management LLC acquired a new position in agilon health in the 3rd quarter worth about $102,000. Finally, Tower Research Capital LLC TRC increased its position in agilon health by 72.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 5,538 shares of the company’s stock worth $130,000 after purchasing an additional 2,330 shares during the last quarter.

Insiders Place Their Bets

In other news, insider Benjamin Kornitzer sold 5,398 shares of the company’s stock in a transaction on Friday, December 16th. The stock was sold at an average price of $16.82, for a total value of $90,794.36. Following the completion of the sale, the insider now owns 10,426 shares in the company, valued at $175,365.32. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, insider Benjamin Kornitzer sold 5,398 shares of the company’s stock in a transaction on Friday, December 16th. The stock was sold at an average price of $16.82, for a total value of $90,794.36. Following the completion of the sale, the insider now owns 10,426 shares in the company, valued at $175,365.32. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Benjamin Shaker sold 28,555 shares of the company’s stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total value of $667,330.35. Following the completion of the sale, the insider now owns 25,625 shares of the company’s stock, valued at approximately $598,856.25. The disclosure for this sale can be found here. In the last quarter, insiders sold 62,770 shares of company stock worth $1,317,360. 3.30% of the stock is owned by company insiders.

About agilon health

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.